Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aggelakopoulou, A. Malamou, D. C. M. Simoes, I. Charalampopoulos, A. Gravanis, V. Panoutsakopoulou (Athens, Heraklion, Greece). LATE-BREAKING ABSTRACT: BNN27, a synthetic derivative of dehydroepiandrosterone, suppresses allergic airway disease. Eur Respir J 2012; 40: Suppl. 56, 2737

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: The role of FcRn in the allergic airway inflammation Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol Source: Annual Congress 2009 - Airway cell biology Year: 2009 LATE-BREAKING ABSTRACT: Nasal and bronchial levels of Th2 cytokines correlate during a virus induced asthma exacerbation Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012 LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 LATE-BREAKING ABSTRACT: DS102: A bioactive lipid for the treatment of chronic pulmonary disorders Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Developing obstructive change over time is dominant in small airways in severe asthma Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012 LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Effect of antioxidants, L-2-oxothiazolidine-4-carboxylic acid and α-lipoic acid, on airway remodeling in chronic model of allergic airway disease Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 5,6,7-Trihydroxy-4´-methoxy-flavanone from Baccharis retusa (asteraceae) attenuates allergen-induced airway inflammation and hyperresponsiveness in mice Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 LATE-BREAKING ABSTRACT: Novel inhaled ROR/c inhibitor for potential treatment of COPD Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Andrographolide helps steroid-resistant cigarette smoke-induced lung injury model to regain steroid sensitivity Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 In utero supplementation with methyl donors enhances allergic airway disease in mice Source: Annual Congress 2009 - Early life origins of asthma and atopy: is epigenetics the key? Year: 2009 LATE-BREAKING ABSTRACT: Effect of inhaled kinase inhibitor on airway inflammation assessed in induced sputum after challenge with inhaled lipopolysaccharide Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Antioxidant, γ-glutamylcysteinylethyl ester, ameliorates airway hyperresponsiveness in a mouse asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006